Gujarat Themis Biosyn Limited (GUJTHEM.BO)
INR 316.15
(8.18%)
INR 316.15
(8.18%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 830.99 Million INR | -1.88% |
| 2022 | 802.16 Million INR | 29.31% |
| 2021 | 620.95 Million INR | 42.99% |
| 2020 | 414.02 Million INR | 29.5% |
| 2019 | 319.05 Million INR | 348.5% |
| 2018 | 91 Million INR | 14.73% |
| 2017 | 62.28 Million INR | 7.15% |
| 2016 | 60.54 Million INR | -0.47% |
| 2015 | 61.06 Million INR | -7.26% |
| 2014 | 65.84 Million INR | 0.95% |
| 2013 | 67.03 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 185.49 Million INR | -15.48% |
| 2024 Q2 | 157.09 Million INR | -15.31% |
| 2023 Q3 | 177.45 Million INR | -0.42% |
| 2023 Q4 | 209.29 Million INR | 17.94% |
| 2023 FY | - INR | -1.88% |
| 2023 Q1 | 245.81 Million INR | 50.57% |
| 2023 Q2 | 178.2 Million INR | -27.5% |
| 2022 Q3 | 139.17 Million INR | -46.05% |
| 2022 Q2 | 257.97 Million INR | 6.6% |
| 2022 Q1 | 242.01 Million INR | 66.98% |
| 2022 FY | - INR | 29.31% |
| 2022 Q4 | 163.25 Million INR | 17.3% |
| 2021 Q2 | 184.45 Million INR | 10.3% |
| 2021 Q4 | 144.93 Million INR | 47.96% |
| 2021 Q1 | 167.23 Million INR | 101.41% |
| 2021 FY | - INR | 42.99% |
| 2021 Q3 | 97.96 Million INR | -46.89% |
| 2020 Q2 | 156.95 Million INR | 110.67% |
| 2020 Q1 | 74.5 Million INR | -44.74% |
| 2020 FY | - INR | 29.5% |
| 2020 Q4 | 83.03 Million INR | -22.33% |
| 2020 Q3 | 106.9 Million INR | -31.89% |
| 2019 Q2 | 25.06 Million INR | 4.08% |
| 2019 FY | - INR | 348.5% |
| 2019 Q4 | 134.82 Million INR | -10.8% |
| 2019 Q3 | 151.14 Million INR | 503.0% |
| 2019 Q1 | 24.08 Million INR | -29.55% |
| 2018 Q2 | 19.23 Million INR | -5.05% |
| 2018 Q1 | 20.25 Million INR | 24.75% |
| 2018 Q4 | 34.18 Million INR | 64.13% |
| 2018 FY | - INR | 14.73% |
| 2018 Q3 | 20.82 Million INR | 8.28% |
| 2017 FY | - INR | 7.15% |
| 2017 Q4 | 16.23 Million INR | 0.87% |
| 2017 Q1 | 15.24 Million INR | -15.97% |
| 2017 Q2 | 15.82 Million INR | 3.8% |
| 2017 Q3 | 16.09 Million INR | 1.73% |
| 2016 Q3 | 15.64 Million INR | 26.43% |
| 2016 Q4 | 18.14 Million INR | 15.97% |
| 2016 Q2 | 12.37 Million INR | -31.12% |
| 2016 Q1 | 17.96 Million INR | -0.7% |
| 2016 FY | - INR | -0.47% |
| 2015 Q1 | 15.9 Million INR | 27.48% |
| 2015 Q4 | 18.09 Million INR | 35.15% |
| 2015 Q3 | 13.38 Million INR | -8.73% |
| 2015 Q2 | 14.66 Million INR | -7.8% |
| 2015 FY | - INR | -7.26% |
| 2014 Q2 | 16.43 Million INR | -2.28% |
| 2014 Q1 | 16.82 Million INR | -12.95% |
| 2014 FY | - INR | 0.95% |
| 2014 Q4 | 12.47 Million INR | -30.0% |
| 2014 Q3 | 17.82 Million INR | 8.46% |
| 2013 Q1 | 13.93 Million INR | -6.34% |
| 2013 Q2 | 17.31 Million INR | 24.26% |
| 2013 FY | - INR | 0.0% |
| 2013 Q3 | 16.46 Million INR | -4.93% |
| 2013 Q4 | 19.32 Million INR | 17.4% |
| 2012 Q4 | 14.87 Million INR | 3.21% |
| 2012 Q1 | 3.85 Million INR | 108.15% |
| 2012 Q3 | 14.41 Million INR | 48.52% |
| 2012 Q2 | 9.7 Million INR | 151.78% |
| 2011 Q3 | -21.64 Million INR | 0.0% |
| 2011 Q4 | -47.28 Million INR | -118.47% |
| 2008 Q4 | 1.82 Million INR | 0.0% |
| 2007 Q4 | 8.17 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| ANG Lifesciences India Limited | 90.66 Million INR | -816.585% |
| Add-Shop E-Retail Limited | 82.61 Million INR | -905.863% |
| Bacil Pharma Limited | -569.32 Thousand INR | 146062.552% |
| BDH Industries Limited | 124.27 Million INR | -568.684% |
| Beryl Drugs Limited | 26.63 Million INR | -3019.464% |
| Cian Healthcare Limited | 122.56 Million INR | -577.992% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -4930.839% |
| Concord Drugs Limited | 40.52 Million INR | -1950.824% |
| Deccan Health Care Limited | 37.5 Million INR | -2115.629% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 30651.25% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -5133.948% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -129996.093% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | -119.921% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -6890.192% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | -36.129% |
| Panchsheel Organics Limited | 189.36 Million INR | -338.827% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -7073.636% |
| Parnax Lab Limited | 243.59 Million INR | -241.132% |
| Makers Laboratories Limited | 25.81 Million INR | -3119.41% |
| Medi-Caps Limited | 4.77 Million INR | -17317.606% |
| MedPlus Health Services Limited | 3.94 Billion INR | 78.914% |
| Phaarmasia Limited | -1.58 Million INR | 52628.066% |
| Parmax Pharma Limited | 22.93 Million INR | -3522.864% |
| Patidar Buildcon Limited | -5.52 Million INR | 15137.894% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | -848.812% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 204778.325% |
| Trident Lifeline Limited | 102.69 Million INR | -709.202% |
| Tyche Industries Limited | 128.2 Million INR | -548.166% |
| Vivanza Biosciences Limited | 11.2 Million INR | -7316.94% |
| PRAVEG LIMITED | 321.43 Million INR | -158.526% |
| Smruthi Organics Limited | 120.31 Million INR | -590.699% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | -1754.732% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | -226.94% |
| Sastasundar Ventures Limited | -203.51 Million INR | 508.325% |
| Transchem Limited | 56.61 Million INR | -1367.902% |
| Trinity League India Limited | -26.25 Million INR | 3265.33% |
| Vikram Thermo (India) Limited | 386.92 Million INR | -114.77% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 2666.46% |
| Sunil Healthcare Limited | 93.07 Million INR | -792.784% |
| Syschem (India) Limited | 70.4 Million INR | -1080.372% |
| Zenith Healthcare Limited | 4.98 Million INR | -16559.864% |
| Zenlabs Ethica Limited | 27.09 Million INR | -2966.851% |
| Mercury Laboratories Limited | 101.18 Million INR | -721.238% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | -833.596% |
| Vasundhara Rasayans Limited | 84.22 Million INR | -886.624% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 650.134% |
| Roopa Industries Limited | 55.7 Million INR | -1391.883% |
| PANJON LTD. | 4.08 Million INR | -20222.671% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 774.059% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 4461.715% |
| Anuh Pharma Limited | 878.5 Million INR | 5.408% |
| Crestchem Limited | 30.33 Million INR | -2639.45% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 7781.586% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | -2955.911% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | -113.635% |
| Trimurthi Limited | -2.47 Million INR | 33627.966% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | -283.664% |
| Norris Medicines Limited | -1.78 Million INR | 46676.596% |
| Veerhealth Care Limited | 15.99 Million INR | -5095.336% |
| Lactose (India) Limited | 201.22 Million INR | -312.974% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 964.08% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | -387.181% |
| Gennex Laboratories Limited | 219.35 Million INR | -278.832% |
| Denis Chem Lab Limited | 224.84 Million INR | -269.58% |
| Colinz Laboratories Limited | 5.42 Million INR | -15209.396% |
| Godavari Drugs Limited | 134.62 Million INR | -517.266% |
| Zenotech Laboratories Limited | 172.64 Million INR | -381.331% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | -85.17% |
| Bharat Parenterals Limited | 265.74 Million INR | -212.707% |
| Coral Laboratories Limited | 227.07 Million INR | -265.954% |
| Evoq Remedies Limited | 6.18 Million INR | -13329.175% |
| Kerala Ayurveda Limited | 70.78 Million INR | -1073.936% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 9793.153% |
| Natural Capsules Limited | 219.9 Million INR | -277.896% |
| Auro Laboratories Limited | 121.73 Million INR | -582.62% |